Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Necitumumab> ?p ?o }
Showing triples 1 to 69 of
69
with 100 triples per page.
- Necitumumab abstract "Necitumumab (proposed INN) is a recombinant human IgG1 monoclonal antibody used as an antineoplastic. It binds to the epidermal growth factor receptor (EGFR). The US FDA approved necitumumab under the brand name Portrazza for use with gemcitabine and cisplatin in previously untreated metastatic squamous non-small-cell lung carcinoma (NSCLC). It was counterproductive in non-squamous non-small-cell lung carcinoma.".
- Necitumumab atcPrefix "L01".
- Necitumumab atcSuffix "XC22".
- Necitumumab casNumber "906805-06-9".
- Necitumumab fdaUniiCode "2BT4C47RUI".
- Necitumumab wikiPageID "21197863".
- Necitumumab wikiPageLength "2597".
- Necitumumab wikiPageOutDegree "12".
- Necitumumab wikiPageRevisionID "707385192".
- Necitumumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Necitumumab wikiPageWikiLink Chemotherapy.
- Necitumumab wikiPageWikiLink Cisplatin.
- Necitumumab wikiPageWikiLink Epidermal_growth_factor_receptor.
- Necitumumab wikiPageWikiLink Food_and_Drug_Administration.
- Necitumumab wikiPageWikiLink Gemcitabine.
- Necitumumab wikiPageWikiLink Immunoglobulin_G.
- Necitumumab wikiPageWikiLink International_nonproprietary_name.
- Necitumumab wikiPageWikiLink Monoclonal_antibody.
- Necitumumab wikiPageWikiLink Non-small-cell_lung_carcinoma.
- Necitumumab wikiPageWikiLink Squamous_epithelial_cell.
- Necitumumab wikiPageWikiLinkText "Necitumumab".
- Necitumumab wikiPageWikiLinkText "necitumumab".
- Necitumumab atcPrefix "L01".
- Necitumumab atcSuffix "XC22".
- Necitumumab c "6436".
- Necitumumab casNumber "906805".
- Necitumumab chemspiderid "none".
- Necitumumab h "9958".
- Necitumumab kegg "D10018".
- Necitumumab mabType "mab".
- Necitumumab molecularWeight "144.84".
- Necitumumab n "1702".
- Necitumumab o "2020".
- Necitumumab s "42".
- Necitumumab source "u".
- Necitumumab target Epidermal_growth_factor_receptor.
- Necitumumab tradename "Portrazza".
- Necitumumab type "mab".
- Necitumumab unii "2".
- Necitumumab verifiedfields "changed".
- Necitumumab verifiedrevid "458283074".
- Necitumumab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Necitumumab wikiPageUsesTemplate Template:Cascite.
- Necitumumab wikiPageUsesTemplate Template:Chemspidercite.
- Necitumumab wikiPageUsesTemplate Template:Drugbankcite.
- Necitumumab wikiPageUsesTemplate Template:Drugbox.
- Necitumumab wikiPageUsesTemplate Template:Fdacite.
- Necitumumab wikiPageUsesTemplate Template:Keggcite.
- Necitumumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Necitumumab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Necitumumab subject Category:Monoclonal_antibodies.
- Necitumumab hypernym Antibody.
- Necitumumab type ChemicalSubstance.
- Necitumumab type Drug.
- Necitumumab type Antibody.
- Necitumumab type Chemical.
- Necitumumab type Drug.
- Necitumumab type ChemicalObject.
- Necitumumab type Thing.
- Necitumumab type Q8386.
- Necitumumab comment "Necitumumab (proposed INN) is a recombinant human IgG1 monoclonal antibody used as an antineoplastic. It binds to the epidermal growth factor receptor (EGFR). The US FDA approved necitumumab under the brand name Portrazza for use with gemcitabine and cisplatin in previously untreated metastatic squamous non-small-cell lung carcinoma (NSCLC). It was counterproductive in non-squamous non-small-cell lung carcinoma.".
- Necitumumab label "Necitumumab".
- Necitumumab sameAs Q6985503.
- Necitumumab sameAs نسيتوموماب.
- Necitumumab sameAs Necitumumab.
- Necitumumab sameAs m.05c4_pr.
- Necitumumab sameAs Q6985503.
- Necitumumab wasDerivedFrom Necitumumab?oldid=707385192.
- Necitumumab isPrimaryTopicOf Necitumumab.